Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of generic olmesartan medoxomil 40 mg vs reference in healthy Thai volunteers under fasting
TCTR20170714002Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of olmesartan in hypertension (HTN) (2 arms), sponsored by International Bio Service. Planned start Oct 2017; status: not yet recruiting.
02
Drugs
olmesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on TCTR20170714002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170714002.